Cargando…
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790606/ https://www.ncbi.nlm.nih.gov/pubmed/31433902 http://dx.doi.org/10.1111/liv.14222 |
_version_ | 1783458808017715200 |
---|---|
author | Schröeder, Sophia E. Pedrana, Alisa Scott, Nick Wilson, David Kuschel, Christian Aufegger, Lisa Atun, Rifat Baptista‐Leite, Ricardo Butsashvili, Maia El‐Sayed, Manal Getahun, Aneley Hamid, Saeed Hammad, Radi ‘t Hoen, Ellen Hutchinson, Sharon J. Lazarus, Jeffrey V. Lesi, Olufunmilayo Li, Wangsheng Binti Mohamed, Rosmawati Olafsson, Sigurdur Peck, Raquel Sohn, Annette H. Sonderup, Mark Spearman, Catherine W. Swan, Tracy Thursz, Mark Walker, Tim Hellard, Margaret Howell, Jessica |
author_facet | Schröeder, Sophia E. Pedrana, Alisa Scott, Nick Wilson, David Kuschel, Christian Aufegger, Lisa Atun, Rifat Baptista‐Leite, Ricardo Butsashvili, Maia El‐Sayed, Manal Getahun, Aneley Hamid, Saeed Hammad, Radi ‘t Hoen, Ellen Hutchinson, Sharon J. Lazarus, Jeffrey V. Lesi, Olufunmilayo Li, Wangsheng Binti Mohamed, Rosmawati Olafsson, Sigurdur Peck, Raquel Sohn, Annette H. Sonderup, Mark Spearman, Catherine W. Swan, Tracy Thursz, Mark Walker, Tim Hellard, Margaret Howell, Jessica |
author_sort | Schröeder, Sophia E. |
collection | PubMed |
description | Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence‐gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints. |
format | Online Article Text |
id | pubmed-6790606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67906062019-10-18 Innovative strategies for the elimination of viral hepatitis at a national level: A country case series Schröeder, Sophia E. Pedrana, Alisa Scott, Nick Wilson, David Kuschel, Christian Aufegger, Lisa Atun, Rifat Baptista‐Leite, Ricardo Butsashvili, Maia El‐Sayed, Manal Getahun, Aneley Hamid, Saeed Hammad, Radi ‘t Hoen, Ellen Hutchinson, Sharon J. Lazarus, Jeffrey V. Lesi, Olufunmilayo Li, Wangsheng Binti Mohamed, Rosmawati Olafsson, Sigurdur Peck, Raquel Sohn, Annette H. Sonderup, Mark Spearman, Catherine W. Swan, Tracy Thursz, Mark Walker, Tim Hellard, Margaret Howell, Jessica Liver Int Reviews Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence‐gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints. John Wiley and Sons Inc. 2019-09-04 2019-10 /pmc/articles/PMC6790606/ /pubmed/31433902 http://dx.doi.org/10.1111/liv.14222 Text en © 2019 The Authors. Liver International published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Schröeder, Sophia E. Pedrana, Alisa Scott, Nick Wilson, David Kuschel, Christian Aufegger, Lisa Atun, Rifat Baptista‐Leite, Ricardo Butsashvili, Maia El‐Sayed, Manal Getahun, Aneley Hamid, Saeed Hammad, Radi ‘t Hoen, Ellen Hutchinson, Sharon J. Lazarus, Jeffrey V. Lesi, Olufunmilayo Li, Wangsheng Binti Mohamed, Rosmawati Olafsson, Sigurdur Peck, Raquel Sohn, Annette H. Sonderup, Mark Spearman, Catherine W. Swan, Tracy Thursz, Mark Walker, Tim Hellard, Margaret Howell, Jessica Innovative strategies for the elimination of viral hepatitis at a national level: A country case series |
title | Innovative strategies for the elimination of viral hepatitis at a national level: A country case series |
title_full | Innovative strategies for the elimination of viral hepatitis at a national level: A country case series |
title_fullStr | Innovative strategies for the elimination of viral hepatitis at a national level: A country case series |
title_full_unstemmed | Innovative strategies for the elimination of viral hepatitis at a national level: A country case series |
title_short | Innovative strategies for the elimination of viral hepatitis at a national level: A country case series |
title_sort | innovative strategies for the elimination of viral hepatitis at a national level: a country case series |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790606/ https://www.ncbi.nlm.nih.gov/pubmed/31433902 http://dx.doi.org/10.1111/liv.14222 |
work_keys_str_mv | AT schroedersophiae innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT pedranaalisa innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT scottnick innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT wilsondavid innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT kuschelchristian innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT aufeggerlisa innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT atunrifat innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT baptistaleitericardo innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT butsashvilimaia innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT elsayedmanal innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT getahunaneley innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT hamidsaeed innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT hammadradi innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT thoenellen innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT hutchinsonsharonj innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT lazarusjeffreyv innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT lesiolufunmilayo innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT liwangsheng innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT bintimohamedrosmawati innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT olafssonsigurdur innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT peckraquel innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT sohnannetteh innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT sonderupmark innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT spearmancatherinew innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT swantracy innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT thurszmark innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT walkertim innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT hellardmargaret innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries AT howelljessica innovativestrategiesfortheeliminationofviralhepatitisatanationallevelacountrycaseseries |